Consent to recontact for future research using linked primary healthcare data: Outcomes and general practice perceptions from the ATHENA COVID-19 study.

IF 2.2 3区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL
Clinical Trials Pub Date : 2025-04-01 Epub Date: 2024-12-29 DOI:10.1177/17407745241304094
Kim Greaves, Amanda King, Zoltan Bourne, Jennifer Welsh, Mark Morgan, Maria Ximena Tolosa, Trisha Johnston, Carissa Bonner, Tony Stanton, Rosemary Korda
{"title":"Consent to recontact for future research using linked primary healthcare data: Outcomes and general practice perceptions from the ATHENA COVID-19 study.","authors":"Kim Greaves, Amanda King, Zoltan Bourne, Jennifer Welsh, Mark Morgan, Maria Ximena Tolosa, Trisha Johnston, Carissa Bonner, Tony Stanton, Rosemary Korda","doi":"10.1177/17407745241304094","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The ATHENA COVID-19 study was set up to recruit a cohort of patients with linked health information willing to be recontacted in future to participate in clinical trials and also to investigate the outcomes of people with COVID-19 in Queensland, Australia, using consent. This report describes how patients were recruited, their primary care data extracted, proportions consenting, outcomes of using the recontact method to recruit to a study, and experiences interacting with general practices requested to release the primary care data.</p><p><strong>Methods: </strong>Patients diagnosed with COVID-19 from 1 January 2020 to 31 December 2020 were systematically approached to gain consent to have their primary healthcare data extracted from their general practice into a Queensland Health database and linked to other datasets for ethically approved research. Patients were also asked to consent to allow future recontact to discuss participation in clinical trials and other research studies. Patients who consented to recontact were later approached to recruit to a long-COVID study. Patients' general practices were contacted to export the patient files. All patient and general practice interactions were recorded. Outcome measures were proportions of patients consenting to data extraction and research, permission to recontact, proportions of general practices agreeing to participate. A thematic analysis was conducted to assess attitudes regarding export of healthcare data, and the proportions consenting to participate in the long-COVID study were also reported.</p><p><strong>Results: </strong>Of 1212 patients with COVID-19, contact details were available for 1155; 995 (86%) were successfully approached, and 842 (85%) reached a consent decision. Of those who reached a decision, 581 (69%), 615 (73%) and 629 (75%) patients consented to data extraction, recontact, and both, respectively. In all, 382 general practices were contacted, of whom 347 (91%) had an electronic medical record compatible for file export. Of these, 335 (88%) practices agreed to participate, and 12 (3%) declined. In total, 526 patient files were exported. The majority of general practices supported the study and accepted electronic patient consent as legitimate. For the long-COVID study, 376 (90%) of those patients recontacted agreed to have their contact details passed onto the long-COVID study team and 192 (53%) consented to take part in their study.</p><p><strong>Conclusion: </strong>This report describes how primary care data were successfully extracted using consent, and that the majority of patients approached gave permission for their healthcare information to be used for research and be recontacted. The consent-to-recontact concept demonstrated its effectiveness to recruit to new research studies. The majority of general practices were willing to export identifiable patient healthcare data for linkage provided consent had been obtained.</p>","PeriodicalId":10685,"journal":{"name":"Clinical Trials","volume":"22 2","pages":"188-199"},"PeriodicalIF":2.2000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Trials","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/17407745241304094","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/12/29 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The ATHENA COVID-19 study was set up to recruit a cohort of patients with linked health information willing to be recontacted in future to participate in clinical trials and also to investigate the outcomes of people with COVID-19 in Queensland, Australia, using consent. This report describes how patients were recruited, their primary care data extracted, proportions consenting, outcomes of using the recontact method to recruit to a study, and experiences interacting with general practices requested to release the primary care data.

Methods: Patients diagnosed with COVID-19 from 1 January 2020 to 31 December 2020 were systematically approached to gain consent to have their primary healthcare data extracted from their general practice into a Queensland Health database and linked to other datasets for ethically approved research. Patients were also asked to consent to allow future recontact to discuss participation in clinical trials and other research studies. Patients who consented to recontact were later approached to recruit to a long-COVID study. Patients' general practices were contacted to export the patient files. All patient and general practice interactions were recorded. Outcome measures were proportions of patients consenting to data extraction and research, permission to recontact, proportions of general practices agreeing to participate. A thematic analysis was conducted to assess attitudes regarding export of healthcare data, and the proportions consenting to participate in the long-COVID study were also reported.

Results: Of 1212 patients with COVID-19, contact details were available for 1155; 995 (86%) were successfully approached, and 842 (85%) reached a consent decision. Of those who reached a decision, 581 (69%), 615 (73%) and 629 (75%) patients consented to data extraction, recontact, and both, respectively. In all, 382 general practices were contacted, of whom 347 (91%) had an electronic medical record compatible for file export. Of these, 335 (88%) practices agreed to participate, and 12 (3%) declined. In total, 526 patient files were exported. The majority of general practices supported the study and accepted electronic patient consent as legitimate. For the long-COVID study, 376 (90%) of those patients recontacted agreed to have their contact details passed onto the long-COVID study team and 192 (53%) consented to take part in their study.

Conclusion: This report describes how primary care data were successfully extracted using consent, and that the majority of patients approached gave permission for their healthcare information to be used for research and be recontacted. The consent-to-recontact concept demonstrated its effectiveness to recruit to new research studies. The majority of general practices were willing to export identifiable patient healthcare data for linkage provided consent had been obtained.

同意使用相关初级卫生保健数据重新联系以进行未来研究:来自ATHENA COVID-19研究的结果和一般实践看法
背景:雅典娜COVID-19研究旨在招募一组具有相关健康信息的患者,这些患者愿意在未来重新联系,以参与临床试验,并在同意的情况下调查澳大利亚昆士兰州COVID-19患者的结果。本报告描述了如何招募患者,提取他们的初级保健数据,同意的比例,使用再接触方法招募研究的结果,以及与要求发布初级保健数据的一般做法互动的经验。方法:系统地接触2020年1月1日至2020年12月31日诊断为COVID-19的患者,以获得同意,将他们的初级卫生保健数据从其全科实践中提取到昆士兰卫生数据库中,并与伦理批准的研究的其他数据集相关联。患者也被要求同意允许将来再次联系,讨论参与临床试验和其他研究。同意重新接触的患者后来被招募参加一项长期的covid研究。联系患者的全科医生导出患者档案。记录了所有患者和全科医生的互动。结果测量是同意数据提取和研究的患者比例,再次接触的许可比例,同意参与的全科医生比例。进行了主题分析,以评估对医疗数据导出的态度,并报告了同意参与长期covid研究的比例。结果:在1212例COVID-19患者中,有1155例可获得联系方式;995例(86%)成功接触,842例(85%)达成同意决定。在做出决定的患者中,分别有581例(69%)、615例(73%)和629例(75%)患者同意提取数据、重新联系,以及两者都同意。总共联系了382家全科医生,其中347家(91%)拥有兼容文件导出的电子病历。其中,335家(88%)诊所同意参与,12家(3%)诊所拒绝参与。总共导出了526份患者文件。大多数全科医生支持这项研究,并承认电子患者同意书是合法的。对于长期covid研究,重新接触的患者中有376人(90%)同意将他们的联系方式传递给长期covid研究团队,192人(53%)同意参加他们的研究。结论:本报告描述了如何使用同意成功提取初级保健数据,以及大多数接触的患者允许将其医疗保健信息用于研究并重新联系。同意再接触的概念证明了它在招募新研究方面的有效性。在征得同意的情况下,大多数全科医生都愿意导出可识别的患者医疗保健数据进行链接。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Clinical Trials
Clinical Trials 医学-医学:研究与实验
CiteScore
4.10
自引率
3.70%
发文量
82
审稿时长
6-12 weeks
期刊介绍: Clinical Trials is dedicated to advancing knowledge on the design and conduct of clinical trials related research methodologies. Covering the design, conduct, analysis, synthesis and evaluation of key methodologies, the journal remains on the cusp of the latest topics, including ethics, regulation and policy impact.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信